Location History:
- Bethesda, MD (US) (2000)
- Rockville, MD (US) (2000 - 2004)
Company Filing History:
5 out of 3,539 
1 out of 1,217 
1 out of 60 
Years Active: 2000-2004
Title: Innovations of Inventor Sergei A Tsarev
Introduction
Sergei A Tsarev is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of diagnostic methods and vaccines for hepatitis E. With a total of 8 patents to his name, Tsarev's work has had a substantial impact on public health.
Latest Patents
One of Tsarev's latest patents involves recombinant proteins of a Pakistani strain of hepatitis E. This strain, known as SAR-55, has been implicated in an epidemic of enterically transmitted non-A, non-B hepatitis. The invention focuses on the expression of the whole structural region of SAR-55, designated open reading frame 2 (ORF-2), in a eukaryotic expression system. The expressed protein is capable of forming HEV virus-like particles, which can serve as an antigen in diagnostic immunoassays and as an immunogen or vaccine to protect against hepatitis E infection.
Career Highlights
Throughout his career, Tsarev has worked with prominent organizations, including the United States of America, as represented by the Secretary, Department of Health and Human Services, and the United States of America as represented by the Department of Health. His work has been instrumental in advancing the understanding and treatment of hepatitis E.
Collaborations
Tsarev has collaborated with esteemed colleagues such as Suzanne U Emerson and Robert H Purcell. These partnerships have further enhanced the quality and impact of his research.
Conclusion
Sergei A Tsarev's innovative work in the field of biotechnology, particularly regarding hepatitis E, showcases his dedication to improving public health through scientific advancements. His contributions continue to influence the development of effective diagnostic methods and vaccines.